Benchmark analyst raised the price target significantly from $158 to $215, maintaining a Buy rating, citing the Kunlun AI chip spinoff and Robotaxi valuation as key catalysts. The company is considering upgrading its Hong Kong listing to primary status to expand mainland investor access and reduce US policy risk. The CFO recently discussed the company's AI investment strategy. These developments follow a period of strong stock performance, with shares up 27% over the last month.